These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 140094

  • 21. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism.
    Hammerstein J, Meckies J, Leo-Rossberg I, Moltz L, Zielske F.
    J Steroid Biochem; 1975 Jun; 6(6):827-36. PubMed ID: 126335
    [No Abstract] [Full Text] [Related]

  • 22. [Therapy of androgenization symptoms: double blind study of an antiandrogen preparation (SH B 209 AB) against neogynon (author's transl)].
    Lachnit-Fixson U, Kaufmann J.
    Med Klin; 1977 Nov 11; 72(45):1922-6. PubMed ID: 144842
    [Abstract] [Full Text] [Related]

  • 23. [Differentiated application of oral contraceptives basing on the different side effects of synthetic progestins (author's transl)].
    Braendle W, Leidenberger F.
    Ther Umsch; 1976 Apr 11; 33(4):231-3. PubMed ID: 137547
    [Abstract] [Full Text] [Related]

  • 24. [Hormonotherapy in acute, idiopathic hirsutism, and seborrheic alopecia (author's transl)].
    Belaube P, Devaux J, Gamby T, Garcin G, Privat Y.
    Sem Hop; 1982 Jul 01; 58(26-27):1650-3. PubMed ID: 6287643
    [Abstract] [Full Text] [Related]

  • 25. Therapy of androgenetic sympatomatology with cyproterone acetate and ethinyl estradiol.
    Schindler AE, Mangold K, Friedrich E, Keller E, Göser R.
    Arch Gynakol; 1978 May 12; 225(2):103-7. PubMed ID: 148876
    [Abstract] [Full Text] [Related]

  • 26. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
    Falsetti L, Dordoni D, Gastaldi C, Gastaldi A.
    Acta Eur Fertil; 1986 May 12; 17(1):19-25. PubMed ID: 2941960
    [Abstract] [Full Text] [Related]

  • 27. [Treatment of acne, hirsutism and alopecia, by cyproterone acetate and ethinyl estradiol].
    Neale C, Krebs D, Bettendorf G.
    Acta Endocrinol Suppl (Copenh); 1971 May 12; 152():13. PubMed ID: 4251532
    [No Abstract] [Full Text] [Related]

  • 28. [Treatment of hirsutism and acne. Sequential inverse therapy with anti-androgen-estrogen].
    Lebeau M, Vokaer R.
    J Gynecol Obstet Biol Reprod (Paris); 1972 May 12; 1(7):715-21. PubMed ID: 4267704
    [No Abstract] [Full Text] [Related]

  • 29. [Experience in treating androgen-dependent diseases (androgenetic alopecia, acne agminata, hirsutism) with the preparation Diane].
    Rubina VV, Korchevaia TA, Kravchenko LIa.
    Vestn Dermatol Venerol; 1986 May 12; (7):21-5. PubMed ID: 2945335
    [No Abstract] [Full Text] [Related]

  • 30. [Long-term treatment of virilized women with cyproterone acetate (author's transl)].
    Abrahamsson L, Hackl H, Lindström B, Sogn J.
    Wien Klin Wochenschr; 1981 Sep 18; 93(17):552-6. PubMed ID: 6458162
    [Abstract] [Full Text] [Related]

  • 31. [Clinical use of ethinyl estradiol in combination with cyproterone acetate. Study based on 50 cases (author's transl)].
    Henrion R, Laveissiere MN.
    Contracept Fertil Sex (Paris); 1982 Oct 18; 10(10):653-7. PubMed ID: 12338447
    [Abstract] [Full Text] [Related]

  • 32. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
    Franks S, Layton A, Glasier A.
    Hum Reprod; 2008 Feb 18; 23(2):231-2. PubMed ID: 18083746
    [Abstract] [Full Text] [Related]

  • 33. [Treatment of virilized women with intramuscular administration of cyproterone acetate].
    Moltz L, Haase F, Schwartz U, Hammerstein J.
    Geburtshilfe Frauenheilkd; 1983 May 18; 43(5):281-7. PubMed ID: 6223851
    [Abstract] [Full Text] [Related]

  • 34. [A new ovulation inhibitor antiandrogen].
    Millet-part A, Blanes-espi A, Ferrer-barriendos J, Siqueira L, Acosta E.
    J Bras Ginecol; 1984 Mar 18; 94(3):91-7. PubMed ID: 12266391
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial.
    Plewig G, Cunliffe WJ, Binder N, Höschen K.
    Contraception; 2009 Jul 18; 80(1):25-33. PubMed ID: 19501212
    [Abstract] [Full Text] [Related]

  • 36. [Treatment of acne and seborrhea using antiandrogens].
    Keller PJ, Fetz A, Schär A, Floersheim Y.
    Schweiz Med Wochenschr; 1978 Oct 21; 108(42):1640-2. PubMed ID: 151916
    [Abstract] [Full Text] [Related]

  • 37. [Long-term studies with an anti-androgen/estrogen combination preparation of its effectiveness, liver tolerance and lipid metabolism in females].
    Kaiser E, Gruner S.
    Geburtshilfe Frauenheilkd; 1991 Apr 21; 51(4):298-303. PubMed ID: 1830560
    [Abstract] [Full Text] [Related]

  • 38. [Effect of a new hormonal contraceptive (Neo-Eunomin) in females with androgenization symptoms].
    Kaiser E.
    Geburtshilfe Frauenheilkd; 1984 Oct 21; 44(10):651-5. PubMed ID: 6083897
    [Abstract] [Full Text] [Related]

  • 39. [The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type].
    Gollnick H, Albring M, Brill K.
    Ann Endocrinol (Paris); 1999 Sep 21; 60(3):157-66. PubMed ID: 10520404
    [Abstract] [Full Text] [Related]

  • 40. [Anti-androgen treatment of hirsutism with cyproterone acetate].
    Kása M, Egyedi K, Raffai S, Török L.
    Z Hautkr; 1990 Dec 21; 65(12):1112-4. PubMed ID: 2150902
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.